Trenbolone hexahydrobenzylcarbonate
Clinical data | |
---|---|
Trade names | Parabolan, Hexabolan |
Routes of administration | Intramuscular injection |
Identifiers | |
| |
CAS Number | 23454-33-3 |
PubChem (CID) | 20055297 |
ChemSpider | 16736552 |
UNII | BNJ7Y3JFF2 |
Chemical and physical data | |
Formula | C26H34O4 |
Molar mass | 410.554 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Trenbolone hexahydrobenzylcarbonate (brand name Parabolan, Hexabolan), or trenbolone cyclohexylmethylcarbonate, also known as estra-4,9,11-trien-17β-ol-3-one 17β-cyclohexylmethylcarbonate, is a synthetic anabolic-androgenic steroid (AAS) of the 19-nortestosterone group and an androgen ester – specifically, the 17β-hexahydrobenzylcarbonate ester of trenbolone – which was marketed in France for human clinical use but has since been discontinued.[1] It was introduced in France in 1980 and voluntarily discontinued by its manufacturer in 1997.[1][2] It acts as a long-acting prodrug of trenbolone when administered via intramuscular injection.
See also
References
Progestogens (and progestins) |
| ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SPRMs | |||||||||||||||||||||||||||||||
Antiprogestogens | |||||||||||||||||||||||||||||||
See also: Androgens and antiandrogens • Estrogens and antiestrogens • Glucocorticoids and antiglucocorticoids • Mineralocorticoids and antimineralocorticoids • Gonadotropins and GnRH |
AR |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
GPRC6A |
| ||||||||||
See also: Estrogenics • Glucocorticoidics • Mineralocorticoidics • Progestogenics • Steroid hormone metabolism modulators • List of androgens/anabolic steroids |
PR |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
mPRs (PAQRs) |
| ||||||||||
See also: Androgenics • Estrogenics • Glucocorticoidics • Mineralocorticoidics • Steroid hormone metabolism modulators |